甘孜频秸电子科技有限公司

Pfizer Oncology Division is responsible for the clinical development and advancement of Pfizer’s pipeline of innovative cancer medicines and treatments. These breakthroughs would not be possible without the thousands of investigator sites, research networks and patients who participate in our clinical trials each year.

We aim to lead the industry by having the most patient centric clinical trials, building on our trusted relationships with our investigator sites and significantly reducing recruitment cycle times. To meet these ambitious goals, we have established a new Site Partnerships and Recruitment Strategy organization that is focused on establishing business to business partnerships with leading research/healthcare institutions and developing comprehensive enrolment strategies for studies and therapeutic areas.

The Regional Strategic Site Partnerships Lead is a critical member of this new team who will be responsible for identifying, building and nurturing business to business relationships with research and healthcare institutions that enrol a significant portion of our clinical trials. The Regional Lead will establish relationships with our newly identified high performing, high volume sites/partners within a specific therapeutic area and work with the C-suite at those institutions to ensure that the sites are set up for success.

We are seeking seasoned, strategic, and passionate colleagues with a proven track record of building strong relationships and conducting business development with research and healthcare institutions. This is a unique opportunity for a senior field medical, site-facing clinical development, or account management colleague who is excited about being a part of a transformational site partnering model that sets the new standard within the industry.

The Strategic Site Partnerships Lead is accountable for building relationships and operational strategies with high volume sites to deliver sustainable high through-put recruitment for their TA/portfolio. Driving the vision of Pfizer Oncology Division